BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22345261)

  • 1. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in low-income and middle-income countries.
    Ayo-Yusuf OA; Burns DM
    Tob Control; 2012 Mar; 21(2):245-51. PubMed ID: 22345261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smokeless tobacco use: harm reduction or induction approach?
    Hatsukami DK; Lemmonds C; Tomar SL
    Prev Med; 2004 Mar; 38(3):309-17. PubMed ID: 14766113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
    Gartner CE; Hall WD; Chapman S; Freeman B
    PLoS Med; 2007 Jul; 4(7):e185. PubMed ID: 17608560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing smokeless tobacco products new tobacco-delivery systems.
    Hatsukami DK; Ebbert JO; Feuer RM; Stepanov I; Hecht SS
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S368-78. PubMed ID: 18021912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The appeal of smokeless tobacco products among young Canadian smokers: the impact of pictorial health warnings and relative risk messages.
    Callery WE; Hammond D; O'Connor RJ; Fong GT
    Nicotine Tob Res; 2011 May; 13(5):373-83. PubMed ID: 21357730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whither tobacco product regulation?
    McNeill A; Hammond D; Gartner C
    Tob Control; 2012 Mar; 21(2):221-6. PubMed ID: 22345253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men.
    Ă–stenson CG; Hilding A; Grill V; Efendic S
    Scand J Public Health; 2012 Dec; 40(8):730-7. PubMed ID: 23117209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Case for Requiring Graphic Warning Labels on Smokeless Tobacco Product Packages.
    Pakhale S; Samet J; Folan P; Leone F; White A;
    Ann Am Thorac Soc; 2016 Mar; 13(3):329-33. PubMed ID: 26784741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.